Literature DB >> 7907450

Virulence factors associated with F165-positive Escherichia coli strains isolated from piglets and calves.

J Harel1, J Fairbrother, C Forget, C Desautels, J Moore.   

Abstract

In this study, 91 F165-positive Escherichia coli isolated from calves and piglets with diarrhea or septicemia were characterized with respect to receptor binding specificity, presence of the aerobactin system, production of colicin V, resistance to the bactericidal effects of serum. Although most F165-positive isolates shared similar DNA sequences with pap operon sequences, less than half of these isolates demonstrated MRHA to P antigen of human red blood cells and Forssman antigen of sheep red blood cells recognized by P and F (or Prs) adhesins respectively. Certain F165-positive isolates sharing similar DNA sequences with both pap and sfa operon sequences demonstrated mannose-resistant hemagglutination of sheep erythrocytes, as observed in human uropathogenic E. coli possessing the prs operon. Most isolates caused mannose-resistant, neuraminidase-resistant hemagglutination of human, equine, feline, and bovine erythrocytes. Thus, F165-positive isolates express one or more adhesins with different receptor binding specificities. An association was observed between the various receptor binding specificities and serogroup. Most F165-positive isolates possessed the aerobactin system and were resistant to the bactericidal effects of serum, but only 38.5% isolates produced colicin V.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7907450     DOI: 10.1016/0378-1135(93)90081-h

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

1.  Presence and characterization of extraintestinal pathogenic Escherichia coli virulence genes in F165-positive E. coli strains isolated from diseased calves and pigs.

Authors:  Hojabr Dezfulian; Isabelle Batisson; John M Fairbrother; Peter C K Lau; Atef Nassar; George Szatmari; Josée Harel
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

2.  Phenotypic and genotypic characterization of virulence factors of Escherichia coli isolated from broiler chickens with simultaneous occurrence of cellulitis and other colibacillosis lesions.

Authors:  S M Gomis; C Riddell; A A Potter; B J Allan
Journal:  Can J Vet Res       Date:  2001-01       Impact factor: 1.310

3.  Escherichia coli cellulitis in broiler chickens: clonal relationships among strains and analysis of virulence-associated factors of isolates from diseased birds.

Authors:  M Ngeleka; J K Kwaga; D G White; T S Whittam; C Riddell; R Goodhope; A A Potter; B Allan
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

4.  Rapid identification of Escherichia coli pathotypes by virulence gene detection with DNA microarrays.

Authors:  Sadjia Bekal; Roland Brousseau; Luke Masson; Gabrielle Prefontaine; John Fairbrother; Josée Harel
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

5.  Role of calf-adapted Escherichia coli in maintenance of antimicrobial drug resistance in dairy calves.

Authors:  Artashes R Khachatryan; Dale D Hancock; Thomas E Besser; Douglas R Call
Journal:  Appl Environ Microbiol       Date:  2004-02       Impact factor: 4.792

Review 6.  Interactions of Intestinal Bacteria with Components of the Intestinal Mucus.

Authors:  Jean-Félix Sicard; Guillaume Le Bihan; Philippe Vogeleer; Mario Jacques; Josée Harel
Journal:  Front Cell Infect Microbiol       Date:  2017-09-05       Impact factor: 5.293

7.  Molecular characterization of Shiga toxin-producing Escherichia coli isolated from ruminant and donkey raw milk samples and traditional dairy products in Iran.

Authors:  Hassan Momtaz; Rahil Farzan; Ebrahim Rahimi; Farhad Safarpoor Dehkordi; Negar Souod
Journal:  ScientificWorldJournal       Date:  2012-07-31

8.  Sialylation and fucosylation modulate inflammasome-activating eIF2 Signaling and microbial translocation during HIV infection.

Authors:  Leila B Giron; Ceylan E Tanes; Mariane H Schleimann; Phillip A Engen; Lisa M Mattei; Alitzel Anzurez; Mohammad Damra; Huanjia Zhang; Kyle Bittinger; Frederic Bushman; Andrew Kossenkov; Paul W Denton; Hiroaki Tateno; Ali Keshavarzian; Alan L Landay; Mohamed Abdel-Mohsen
Journal:  Mucosal Immunol       Date:  2020-03-09       Impact factor: 7.313

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.